Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy Korea Infants

PHASE3RecruitingINTERVENTIONAL

Enrollment

245

Participants

Timeline

Start Date

October 23, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

June 30, 2025

Conditions

Healthy

Interventions

BIOLOGICAL

IL-YANG FLU Vaccine Prefilled Syringe INJ.

Teratect Prefilled Syringe Inj. 0.5mL

BIOLOGICAL

Fluarix Tetra Pre-filled Syringe

Fluarix Tetra Pre-filled Syringe 0.5mL

Trial Locations (2)

NOT_YET_RECRUITING

Korea University ANSAN Hospital, Ansan-si

RECRUITING

The Catholic University of Korea, Bucheon St. Mary's Hospital, Bucheon-si

All Listed Sponsors

lead

Il-Yang Pharm. Co., Ltd.

INDUSTRY